Abbott LaboratoriesABT
Price$98.83Intrinsic value$108.4610% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $108.46median of 6 methods · middle span $91-$141based on filings through 31 Mar 2026
Market Price $98.83Price as of 30 Sep 2026
Margin of Safety +9.7%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 4.1% (near-term consensus, capped) · years 2–5: 10.7%/yr (balance of the path).9.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 610.4%Yr 710.1%Yr 89.8%Yr 99.6%Yr 109.3%
10.7% → 9.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 118.7%Yr 128.0%Yr 137.4%Yr 146.8%Yr 156.2%Yr 165.5%Yr 174.9%Yr 184.3%Yr 193.6%Yr 203.0%
9.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)10.4%
Discount rate (cost of equity) 8.2%
Volatility vs market (adjusted beta)0.72

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAbbott LaboratoriesABTHealth Care
Valuation
P/E27.7×
P/S3.9×
P/B3.4×
EV / Revenue4.5×
EV / EBITDA—
Profitability
Gross margin—
Operating margin17.1%
Net margin13.9%
FCF margin16.3%
Returns
ROE12.1%
ROA5.7%
ROIC7.9%
Growth
Revenue growth (YoY)7.6%
5-yr fwd EPS growth9.3%
Financial strength
Debt / Equity0.65×
Current ratio1.39×
Altman Z-Score3.2
Interest coverage—
Dividend yield1.8%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.